Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients

被引:94
|
作者
Peterseim, DS
Cen, YY
Cheruvu, S
Landolfo, K
Bashore, TM
Lowe, JE
Wolfe, WG
Glower, DD
机构
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
来源
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 1999年 / 117卷 / 05期
关键词
D O I
10.1016/S0022-5223(99)70368-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The purpose of this study was to optimize selection criteria of biologic versus mechanical valve prostheses for aortic valve replacement. Methods: Retrospective analysis was performed for 841 patients undergoing isolated, first-time aortic valve replacement with Carpentier-Edwards (n = 429) or St Jude Medical (n = 412) prostheses. Results: Patients with Carpentier-Edwards and St Jude Medical valves had similar characteristics. Ten-gear survival was similar in each group (Carpentier-Edwards 54% +/- 3% versus St Jude Medical 50% +/- 6%; P =.4), Independent predictors of worse survival were older age, renal or lung disease, ejection fraction less than 40%, diabetes, and coronary disease. Carpentier-Edwards versus St Jude Medical prostheses did not affect survival (P =.4). Independent predictors of aortic valve reoperation were younger age and Carpentier-Edwards prosthesis. The linearized rates of thromboembolism were similar, but the linearized rate of hemorrhage was lower with Carpentier-Edwards prostheses (P <.01), Perivalvular leak within 6 months of operation was more likely with St Jude Medical than with Carpentier-Edwards prostheses (P =.02). Estimated 10-year survival free from valve-related morbidity was better for the St Jude Medical valve in patients aged less than 65 Sears and was better for the Carpentier-Edwards valve in patients aged more than 65 years. Patients with renal disease, lung disease tin patients more than age 60 years), ejection fraction less than 40%, or coronary disease had a life expectancy of less than 10 years. Conclusions: For first-time, isolated aortic valve replacement, mechanical prostheses should be consider ed in patients under age 65 years with a life expectancy of at least 10 years. Bioprostheses should be considered in patients over age 65 years or with lung disease tin patients over age 60 Sears), renal disease, coronary disease, ejection fraction less than 40%, or a life expectancy less than 10 years.
引用
收藏
页码:890 / 897
页数:8
相关论文
共 50 条
  • [1] Long-term survival after biological versus mechanical aortic valve replacement in 1156 patients
    Peterseim, D
    Cen, YY
    Cheruvu, S
    Wolfe, WG
    Landolfo, K
    Lowe, JE
    Glower, DD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 98166 - 98166
  • [2] Very long-term outcomes of aortic valve replacement with mechanical versus tissue aortic valve prosthesis in young patients
    Mohty, D
    Avierinos, JF
    Daly, RC
    Sarano, ME
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 486A - 486A
  • [3] Long-term neurocognitive function after mechanical aortic valve replacement
    Zimpfer, D
    Czerny, M
    Schuch, P
    Fakin, R
    Madl, C
    Wolner, E
    Grimm, M
    ANNALS OF THORACIC SURGERY, 2006, 81 (01): : 29 - 33
  • [4] Long-term outcome after mitral valve replacement using biological versus mechanical valves
    Cetinkaya, Ayse
    Poggenpohl, Julia
    Bramlage, Karin
    Hein, Stefan
    Doss, Mirko
    Bramlage, Peter
    Schoenburg, Markus
    Richter, Manfred
    JOURNAL OF CARDIOTHORACIC SURGERY, 2019, 14 (1)
  • [5] Long-term outcome after mitral valve replacement using biological versus mechanical valves
    Ayse Cetinkaya
    Julia Poggenpohl
    Karin Bramlage
    Stefan Hein
    Mirko Doss
    Peter Bramlage
    Markus Schönburg
    Manfred Richter
    Journal of Cardiothoracic Surgery, 14
  • [6] Perioperative and long-term outcomes of Ross versus mechanical aortic valve replacement
    Wenos, Chelsea D.
    Herrmann, Jeremy L.
    Timsina, Lava R.
    Patel, Parth M.
    Fehrenbacher, John W.
    Brown, John W.
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (10) : 2963 - 2971
  • [7] Long-Term Risk for Aortic Complications After Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Versus Marfan Syndrome
    Itagaki, Shinobu
    Chikwe, Joanna P.
    Chiang, Yuting P.
    Egorova, Natalia N.
    Adams, David H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (22) : 2363 - 2369
  • [8] Short- and long-term outcome after surgical aortic valve replacement in patients on dialysis
    Perrotta, Sossio
    Nielsen, Susanne J.
    Hansson, Emma C.
    Lepore, Vincenzo
    Martinsson, Andreas
    Jeppsson, Anders
    Lindgren, Martin
    JOURNAL OF THORACIC DISEASE, 2022, 14 (02) : 269 - +
  • [9] Short- and long-term outcome after surgical aortic valve replacement in patients on dialysis
    Perrotta, Sossio
    Nielsen, Susanne J.
    Hansson, Emma C.
    Lepore, Vincenzo
    Martinsson, Andreas
    Jeppsson, Anders
    Lindgren, Martin
    JOURNAL OF THORACIC DISEASE, 2021,
  • [10] Long-Term Outcome of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement for Aortic Stenosis: A Meta-Analysis
    Putra, Hendy Bhaskara Perdana
    Juslim, Richardus Rukma
    Jovie, Benny
    Pintaningrum, Yusra
    Rahadisiwi, Sekar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (15) : S14 - S14